Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Kazuhiko Arima has a total of 458 co-authors. Here are the top co-authors by number of shared publications:

  • Mami Tamai

    Department of Immunology and Rheumatology, Nagasaki University Graduate School of Biomedical Sciences, Nagasaki, Japan

    65 shared publications
  • Atsushi Kawakami

    Leading Medical Research Core Unit, Nagasaki University Graduate School of Biomedical Sciences Nagasaki Japan

    52 shared publications
  • Hideki Nakamura

    B Department of Immunology and Rheumatology , Graduate School of Biomedical Sciences, Nagasaki University , Japan

    45 shared publications
  • Tomoki Origuchi

    39 shared publications
  • Katsumi Eguchi

    Department of Rheumatology, Sasebo Chuo Hospital, Sasebo-city, Japan

    31 shared publications
  • Hiroaki Ida

    Division of Respirology, Neurology, and Rheumatology, Department of Medicine, Kurume University School of Medicine

    29 shared publications

Latest Publications

  • Association Between End‐of‐Life Care Practice in Long‐Term Care Facilities and Interprofessional Collaboration With External Facilities: A Questionnaire Survey

    by Kengo Maeda, Kazuhiko Arima, Satoshi Mizukami, Reiko Furugen, Tetsuro Niri, Shin‐Ya Kawashiri, Yasuhiro Nagata

    Aim: This study aimed to examine the association between end‐of‐life (EOL) care practices in long‐term care (LTC) facilities and collaboration with external facilities. Methods: This was a cross‐sectional study. Data were obtained from the Survey for Home Medical Care and Long‐Term Care Collaboration, conducted by the Nagasaki City Office. Responses from representatives of LTC facilities were analyzed to assess the association between EOL care practice in LTC facilities and perceived interprofessional collaboration (IPC) with external facilities. Logistic regression analysis was used to evaluate the associations between EOL care practices and IPC with clinics, dental clinics, pharmacies, and home‐visit nursing stations, adjusting for facility type, number of residents, presence of a full‐time physician, availability of nurses during night shifts or on‐call hours, and medical care capacity. Results: Among the 152 facilities, 86 practiced EOL care. Collaboration with dental clinics was significantly associated with EOL care practice (adjusted OR = 2.31, 95% CI: 1.06–5.04, p = 0.035). No significant associations were found for collaboration with clinics, pharmacies, or home‐visit nursing stations. Conclusions: EOL care practice in LTC facilities was associated with collaboration with dental clinics. Strengthening IPC, particularly with dental professionals, may enhance the quality of EOL care, thereby serving as an effective strategy for expanding EOL care services in rapidly aging societies.


  • Open Access

    Association Between Women’s Birth Weight and Reproductive Characteristics in Adulthood: The JPHC-NEXT Study

    by Shiori Itoi, Chie Nagata, Aurelie Piedvache, Naho Morisaki, Kohei Ogawa, Yoshiko Yamamoto, Isao Saito, Koutatsu Maruyama, Kazuhiko Arima, Kiyoshi Aoyagi, et al.

    Background: We aimed to investigate the association between women’s birth weight and their reproductive characteristics.Methods: We used data from the Japan Public Health Center-based Prospective Study for the Next Generation (JPHC-NEXT), a population-based cohort in Japan. The main analysis included 40,796 women aged 40 to 68 years. Outcomes of interest were age at menarche, age at menopause, history of menstrual irregularity, and nulliparity. Associations between self-reported birth weight categories and outcomes were assessed using either a linear regression or a modified Poisson regression adjusted for potential confounders.Results: Among participants with complete data, those with lower birth weights (<1,500 g and 1,500–2,499 g) compared to women with a birth weight of 3,000–3,999 g had a later age at menarche (adjusted mean difference [aMD]: 2.4 months and 2.0 months, respectively), earlier age at menopause (aMD: −6.7 months and −2.7 months, respectively), and therefore a shorter reproductive span (aMD: −7.7 months and −4.5 months, respectively). They also had a higher risk of menstrual irregularity (adjusted relative risk [aRR]: 1.19 and 1.11, respectively) and a higher likelihood of nulliparity (aRR: 1.25 and 1.19, respectively).Conclusion: We observed that Japanese women’s birth weight was significantly associated with reproductive characteristics. Specifically, those with a low birth weight had a shorter reproductive span and a higher risk of irregular menses and nulliparity compared to those with a normal birth weight.


  • Open Access

    Association between polypharmacy and the risk of requiring long‐term care among community‐dwelling older residents: A retrospective cohort study

    by Kengo Maeda, Shin‐Ya Kawashiri, Kazuhiko Arima, Tetsuro Niri, Yukiko Honda, Jun Miyata, Fumiaki Nonaka, Hirokazu Kumazaki, Takahiro Maeda, Yasuhiro Nagata

    Background: Polypharmacy has been increasing attention as it is associated with a number of health problems, especially adverse outcomes in older adults. However, there is insufficient evidence regarding the risk of polypharmacy and long‐term care.Methods: We analyzed a community‐based retrospective cohort of residents of Goto City by combining data from health checkups, prescription information, and long‐term care needs certification database. The study sample included residents aged 65–79 years in 2015 who were followed up for 4 years. The number of medications used was categorized as 0, 1–5, 6–9, and ≥10. The outcome was initiation of long‐term care. Cox regression models were used to calculate hazard ratios (HRs) with 95% confidence intervals (CIs) adjusted for potential confounders.Results: Among 1083 participants, 58 used long‐term care for 4 years. Compared with participants taking no medication, the incidence of long‐term care initiation was approximately double in those taking 1–5 medications, four times higher in people taking 6–9 medications, and 13 times higher in people taking ≥10 medications. After adjusting for potential baseline confounders, the number of medications was significantly associated with the initiation of long‐term care services (1–5 drugs: adjusted HR 2.38, 95% CI 1.06–5.34; 6–9 drugs: adjusted HR 2.97, 95% CI 1.23–7.15; and ≥10 drugs: adjusted HR 5.54, 95% CI 1.89–16.23).Conclusions: Among community‐dwelling residents aged 65–79 years, the risk of requiring long‐term care had a dose–response relationship with the number of prescribed medications.


  • Open Access

    Association between anti-thyroid peroxidase antibody and insufficient sleep in euthyroid population

    by Yuji Shimizu, Yuko Noguchi, Nagisa Sasaki, Mutsumi Matsuu-Matsuyama, Shin-Ya Kawashiri, Hirotomo Yamanashi, Kazuhiko Arima, Seiko Nakamichi, Yasuhiro Nagata, Naomi Hayashida, et al.


  • Open Access

    Anti–early antigen Epstein-Barr virus titer and atherosclerosis in relation to vascular endothelial growth factor (VEGF) polymorphism rs3025039 among older Japanese individuals

    by Yuji Shimizu, Hirotomo Yamanashi, Shin-Ya Kawashiri, Yuko Noguchi, Nagisa Sasaki, Seiko Nakamichi, Kazuhiko Arima, Yasuhiro Nagata, Takahiro Maeda

    Background: Epstein-Barr (EB) virus infection stimulates the production of vascular endothelial growth factor (VEGF), which contributes to the progression of angiogenesis. Angiogenesis plays an important role in the development of atherosclerosis. Since serum anti-early antigen EB virus IgG (EBV EA-IgG) titer is a sign of active EB virus infection, EBV EA-IgG titer could be associated with atherosclerosis. The number of minor (T) alleles in VEGF polymorphism rs3025039 has been reported to be inversely associated with serum VEGF concentration, suggesting that rs3025039 might have a strong influence on the association between EBV EA-IgG titer and atherosclerosis. By focusing on the role of VEGF in the development of atherosclerosis, this study aimed to investigate the association between active EB virus infection and atherosclerosis.Methods: A cross-sectional study of 2,661 older Japanese individuals aged 60–89 years who participated in annual health check-ups during 2017–2019 was conducted. Logistic regression was used to evaluate the association between EBV EA-IgG titer and atherosclerosis in relation to rs3025039 genotype. The influence of rs3025039 (T) allele carrier status on the association between EBV EA-IgG titer and atherosclerosis was also evaluated by using logistic regression.Results: Among rs3025039 CC-homozygotes, with the lowest EBV EA-IgG titer tertile as the reference, the multivariable odds ratio (95% confidence interval) was 1.11 (0.82, 1.50) for the medium tertile and 1.07 (0.78, 1.47) for the high tertile. Among rs3025039 (T) allele carriers, the corresponding values were 1.44 (0.88, 2.36) and 1.88 (1.15, 3.05), respectively. There was a significant interaction between rs3025039 (T) allele carrier status and the association between EBV EA-IgG titer and atherosclerosis (adjusted p = 0.0497).Conclusion: EBV EA-IgG titer was significantly positively associated with atherosclerosis only among participants who are genetically less likely to have progressive angiogenesis. An angiogenesis-related genetic factor was revealed as a determinant of the association between EBV EA-IgG titer and atherosclerosis. These findings introduce a novel concept that could explain the association between viral infection and atherosclerosis.


  • Open Access

    Association Between Birth Weight and Prevalence of Cardiovascular Disease and Other Lifestyle-related Diseases Among the Japanese Population: The JPHC-NEXT Study

    by Keisuke Yoshii, Naho Morisaki, Aurélie Piedvache, Shinya Nakada, Kazuhiko Arima, Kiyoshi Aoyagi, Hiroki Nakashima, Nobufumi Yasuda, Isao Muraki, Kazumasa Yamagishi, et al.

    Background: An association between birth weight and cardiovascular disease (CVD) in adulthood has been observed in many countries; however, only a few studies have been conducted in Asian populations.Methods: We used data from the baseline survey (2011–2016) of the Japan Public Health Center-based Prospective Study for the Next Generation Cohort, which included 114,105 participants aged 40–74 years. Adjusted prevalence ratios (aPRs) and 95% confidence intervals (CIs) were calculated from the prevalence of present and past histories of CVD and other lifestyle-related diseases, including hypertension, diabetes, hyperlipidemia, and gout, by birth weight, using Poisson regression.Results: The prevalence of CVD increased with lower birth weight, with the highest prevalence among those with birth weight under 1,500 grams (males 4.6%; females 1.7%) and the lowest one among those with birth weight at or over 4,000g (males 3.7%: females 0.8%). Among 88.653 participants (41,156 males and 47,497 females) with complete data on possible confounders, birth weight under 1,500g was associated with a higher prevalence of CVD (aPR 1.76 [95%CI 1.37-2.26]), hypertension (aPR 1.29 [95%CI 1.17–1.42]), and diabetes (aPR 1.53 [95%CI 1.26–1.86]) when a birth weight of 3,000–3,999 grams was used as the reference. Weaker associations were observed for birth weight of 1500–2499 grams and 2500–2999 grams, while no significant associations were observed for birth weight at or over 4000 g. The association between birth weight and the prevalence of hyperlipidemia was less profound, and no significant association was observed between birth weight and gout.Conclusion: Lower birth weight was associated with a higher prevalence of CVD, hypertension, and diabetes in the Japanese population.


  • Period prevalence of uveitis in human T‐lymphotropic virus 1 carriers versus noncarriers in a highly endemic area: The Nagasaki Islands Study

    by Jun Miyata, Hirotomo Yamanashi, Yoshinori Dake, Kenichi Nobusue, Yusuke Doi, Yukiko Honda, Fumiaki Nonaka, Kazuhiko Arima, Mami Tamai, Daisuke Sasaki, et al.

    The magnitude of the effect of human T‐lymphotropic virus 1 (HTLV‐1) infection on uveitis remains unclear. We conducted a cross‐sectional study in a highly endemic area of HTLV‐1 in Japan. The study included 4265 residents (men, 39.2%), mostly middle‐aged and older individuals with a mean age of 69.9 years, who participated in our surveys between April 2016 and September 2022. We identified HTLV‐1 carriers by screening using chemiluminescent enzyme immunoassays and confirmatory tests, and the proportion of carriers was 16.1%. Participants with uveitis were determined from the medical records of all hospitals and clinics where certified ophthalmologists practiced. We conducted logistic regression analyses in an age‐ and sex‐adjusted model to compute the odds ratio (OR) and 95% confidence interval (CI) of uveitis according to HTLV‐1 infection status. Thirty‐two (0.8%) participants had uveitis. For HTLV‐1 carriers, the age‐ and sex‐adjusted OR (95% CI) of uveitis was 3.27 (1.57–6.72) compared with noncarriers. In conclusion, HTLV‐1 infection was associated with a higher risk of uveitis among mostly middle‐aged and older Japanese residents in a highly endemic HTLV‐1 area. Our findings suggest that physicians who treat HTLV‐1 carriers should assess ocular symptoms, and those who diagnose patients with uveitis should consider HTLV‐1 infection.


  • Open Access

    Profile of Nagasaki Islands Study (NaIS): A Population-based Prospective Cohort Study on Multi-disease

    by Jun Miyata, Hirotomo Yamanashi, Shin-Ya Kawashiri, Sakiko Soutome, Kazuhiko Arima, Mami Tamai, Fumiaki Nonaka, Yukiko Honda, Masayasu Kitamura, Koji Yoshida, et al.

    In an aging society, it is important to visualize the conditions of people living with diseases or disabilities, such as frailty and sarcopenia, and determine the environmental and genetic factors underlying such conditions. Atherosclerosis and arterial stiffness are key conditions between these factors and noncommunicable diseases. In 2014, we launched a population-based prospective open-cohort study, the Nagasaki Islands Study (NaIS), which was conducted in Goto City, located in the remote islands of Nagasaki Prefecture, Japan, mostly involving middle-aged and older residents. We conducted our own health checkups along with the annual standardized checkups organized by the municipality; recruited study participants; and started to follow-up with them for vital status (death), migration, and occurrence of diseases such as myocardial infarction, stroke, fracture, and human T-cell leukemia virus type 1 (HTLV-1) -associated uveitis. Our checkups were conducted as baseline surveys in different areas of Goto City during the fiscal years 2014–2016, secondary surveys during 2017–2019, and tertiary surveys since 2021, consisting of medical interviews, physical examinations, blood and urine tests, body composition measurements, osteoporosis screening, arterial stiffness measurements, carotid ultrasonography, and dental examination. A total of 4,957 residents participated in either the baseline or secondary surveys and were followed-up; and 3,594 and 3,364 residents (aged 27–96 and 28–98 years) participated in the baseline and secondary surveys, respectively. In conclusion, the NaIS has been undertaken to reveal the influence of aging and risk factors of noncommunicable diseases and disabilities, with an aim to contribute towards better healthcare in the future.


  • Non‐liver‐related mortality in the DAA era: Insights from post‐SVR patients with and without previous HCC history

    by Satoshi Miuma, Hisamitsu Miyaaki, Tatsuki Ichikawa, Toshihisa Matsuzaki, Takashi Goto, Yasuhiro Kamo, Masaya Shigeno, Naoyuki Hino, Keisuke Ario, Kenji Yanagi, et al.

    Background and Aims: Mortality after sustained virological response (SVR) with interferon‐free direct‐acting antiviral (IFN‐free DAA) therapy is crucial for optimizing post‐SVR patient care, but it remains unclear, especially regarding non‐liver‐related mortality.Methods: Consecutive post‐SVR patients from 14 institutions were stratified into three cohorts: A (without advanced fibrosis and without prior HCC), B (with advanced fibrosis and without prior HCC), and C (curative HCC treatment). We assessed mortality (per 1000 person‐years [/1000PY]) post‐SVR. Mortality rates were compared between cohorts A and B and the general population using age‐ and sex‐adjusted standardized mortality ratio (SMR). Comparison of survival between each cohort was performed using propensity‐score (PS) matching with sex, age, and comorbidity.Results: In cohort A (n = 762; median age, 65 years), 22 patients died (median follow‐up, 36 months); all‐cause mortality was 10.0/1000PY, with 86.4% non‐liver‐related deaths. In cohort B (n = 519; median age, 73 years), 27 patients died (median follow‐up, 39 months); all‐cause mortality was 16.7/1000PY, with 88.9% non‐liver‐related deaths. In both cohorts, malignant neoplasm was the most common cause of death; all‐cause mortality was comparable to that of the general population (SMR: 0.96 and 0.92). In cohort C (n = 108; median age, 75 years), 15 patients died (median follow‐up, 51 months); all‐cause mortality was 36.0/1000PY, with 53.3% liver‐related deaths. PS matching showed no significant survival differences between cohorts A and B, both of which had better survival than cohort C.Conclusions: Mortality varies based on HCC history in the DAA era; nevertheless, attention should be paid to non‐liver‐related deaths in all post‐SVR patients.


  • Open Access

    Association between physical performance and bone mass in community-dwelling postmenopausal Japanese women: The Unzen study

    by Masahiro Suiko, Satoshi Mizukami, Kazuhiko Arima, Hiroki Nakashima, Takayuki Nishimura, Yoshihito Tomita, Yasuyo Abe, Natsumi Tanaka, Yuzo Honda, Michiko Kojima, et al.

    Background: Low bone mass is an independent risk factor for osteoporotic fractures. We examined the association between physical performance and bone mass using quantitative ultrasound in community-dwelling postmenopausal Japanese women. Methods: We conducted a cross-sectional study on 524 community-dwelling postmenopausal Japanese women who were not being administered osteoporosis medications. Physical performance was assessed on the basis of grip strength, chair stand time, and functional reach. The stiffness index was measured as a quantitative ultrasound parameter for heel bone mass. Results: Physical performance, assessed by grip strength, chair stand time, and functional reach, and the stiffness index significantly decreased with age (both p<0.001). The multiple linear regression analysis showed that grip strength (p = 0.001), chair stand time (p = 0.004), and functional reach (p = 0.048) were significantly associated with the stiffness index after adjusting for age, body mass index, smoking, drinking, and exercise. Conclusions: Physical performance was significantly associated with heel bone mass in community-dwelling postmenopausal Japanese women.